January 06, 2016
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: Anifrolumab continues in trial for patients with SLE
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
SAN FRANCISCO — Jörn Drappa, MD, PhD, spoke to Healio Rheumatology about the anifrolumab in the Medimmune pipeline.
Drappa is the vice president of clinical development at Medimmune.